Sysmex America, Inc. Launches Vital Educational Sections on Website to Aid Clinicians and Laboratory Professionals in Understanding the Role of Advanced Clinical Parameters in Diagnosis, Prognosis and Treatment of Disease

Feb 17, 2016, 11:00 ET from Sysmex America, Inc.

LINCOLNSHIRE, Ill., Feb. 17, 2016 /PRNewswire/ -- Sysmex America, Inc., a global leader in automated hematology diagnostics, today announced the launch of two new educational sections on its website that can provide vital information to clinicians, physicians and laboratory professionals. The sections, and, include case studies, videos, webinars and scientific data about Sysmex Advanced Clinical Parameters (ACPs), which are sophisticated laboratory tests that provide additional information about the state of blood cells. ACPs expand the Complete Blood Count (CBC) laboratory test and aid in the detection of several hematological conditions.

"The clinicians and physicians who are already using our ACPs have found them helpful in detecting and differentiating a wide variety of hematological conditions, including anemia, infection, inflammation and potentially life-threatening conditions," said Jolanta Kunicka, Ph.D., director scientific marketing.

"Sysmex places a very high priority on education, and these new sections of our website are part of our growing portfolio of educational tools," she said. Kunicka's scientific marketing department is comprised of registered nurses who work collaboratively with clinicians and laboratorians using these clinical parameters to provide better patient care. The new website sections include a wide variety of information about Sysmex ACPs:

Infection and Inflammation: How advanced quantitative measurement of Immature Granulocyte (IG) populations may identify left shift and improve the assessment of infections and inflammation. According to the new laboratorians section, there is an incremental savings associated with automated accurate IG count versus traditional manual methodologies.

Erythropoiesis and Anemia Management: How to evaluate and monitor acute changes in hemoglobinization at the cellular level for earlier detection of iron deficiency anemia using Reticulocyte Hemoglobin (RET-He). This advanced parameter has been used by physicians in identifying and managing anemia in high risk populations such as young children, patients with chronic disease, pre-surgical patients and cancer patient populations.

Thrombopoiesis: How Immature Platelet Fraction (IPF) can be used to more specifically assess and monitor thrombocytopenia, particularly in cancer and pediatric patients.

About Sysmex America, Inc.

Sysmex America, Inc., is a trusted world leader that distributes and supports a diverse portfolio of best-in-class, in vitro diagnostic hematology and clinical laboratory products in the U.S., Canada and Latin America. It is the U.S. headquarters of Sysmex Corporation, located in Kobe, Japan, a trusted world leader in clinical laboratory systemization and solutions that optimize efficiency, operations and financial performance in the lab. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex America, visit

Logo - 


SOURCE Sysmex America, Inc.